April 5th 2021, 4:15pm
Results of a retrospective cohort study show that although adherence to erenumab was higher than that reported with tradition oral prophylactic migraine therapies, overall adherence among US adult migraineurs is suboptimal.
December 30th 2020, 11:30am
December 26th 2020, 4:30pm
Wayne Jonas, MD, executive director of Samueli Integrative Health Programs at H&S Ventures, discusses what new therapies are emerging in the world of pain management.
December 22nd 2020, 4:41pm
The researchers said their results have potential implications for pain management and wellness in older adults, and they suggest that pain catastrophizing could be an important therapeutic target for interventions and pain treatment.
December 19th 2020, 10:30pm
The finding about mindfulness-based stress reduction (MBSR) was a secondary outcome of the double-blinded, randomized, placebo-controlled clinical trial. The primary outcome—a reduction in the frequency of migraines—was not reached.
December 19th 2020, 4:30pm
Wayne Jonas, MD, executive director of Samueli Integrative Health Programs at H&S Ventures, discusses what foods he recommends including and excluding from patients' diets to help manage pain.
December 12th 2020, 11:45pm
Scientists in Japan describe how a population of spinal cord astrocytes appear to have a role in producing pain hypersensitivity.
December 12th 2020, 4:30pm
Wayne Jonas, MD, executive director of Samueli Integrative Health Programs at H&S Ventures, discusses current nondrug therapies available to patients to manage chronic and acute pain.
December 5th 2020, 8:00pm
Wayne Jonas, MD, executive director of Samueli Integrative Health Programs at H&S Ventures, discusses the unmet needs that still exist for patients with pain.
December 5th 2020, 5:00pm
Previous studies have suggested that migraine is linked with higher visual neuronal excitability, which can be inhibited through noninvasive brain stimulation.
